A Win For Adaptimmune Therapeutics plc

Mon 13 Jan 20 at 05:30 PM
A Win For Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc (ADAP:NASDAQ) jumped higher at $3.99, representing a gain of 200%. On Fri 10 Jan 20, ADAP:NASDAQ hit a New 2-Week Intraday High of $1.42. From Thu 19 Dec 19, the stock recorded 57.14% Up Days and 40.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About Adaptimmune Therapeutics plc (ADAP:NASDAQ)

Adaptimmune Therapeutics PLC along with its subsidiaries is a clinical-stage biopharmaceutical company. It is engaged in novel cancer immunotherapy products based on its T-cell receptor platform.

Share